N-(2-Amino-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)-4-methoxybenzamide

Catalog No. :
ACSGYA157
CAS No. :
74149-74-9
Molecular Formula :
C19H20N4O3
Molecular Weight :
352.39

IUPAC Name:N-(2-amino-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)-4-methoxybenzamide

N-(2-Amino-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)-4-methoxybenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-Amino-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)-4-methoxybenzamide
IUPAC NameN-(2-amino-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)-4-methoxybenzamide
Molecular FormulaC19H20N4O3
Molecular Weight352.39
SMILESO=C(NC1=CC=C(C(C(C)C2)=NNC2=O)C=C1N)C3=CC=C(OC)C=C3
InChI KeyWJMJXFIZZSXKST-UHFFFAOYSA-N
SynonymBenzamide,N-[2-amino-4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-4-methoxy-;N-[2-Amino-4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-4-methoxybenzamide;Pimobendan EP Impurity B;Pimobendan Related Compound B (N-[2-Amino-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl (1569337);N-[2-Amino-4-[(4RS)-4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl]phenyl]-4-methoxybenzamide
CAS No.74149-74-9

Synthetic Route by SureRoute

1. ACSGYA157 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSGYA157 route product structure diagram
    ACSGYA15774149-74-9
Inquiry

2. ACSGYA157 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUFOZ697 route compound structure diagram
    ACUFOZ69774150-02-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSGYA157 route product structure diagram
    ACSGYA15774149-74-9
Inquiry

Comments (0)